GeneLink names new CEO
This article was originally published in Clinica
Executive Summary
Gary Beeman has been appointed CEO and president of consumer genomics specialist GeneLink BioSciences. He replaces interim CEO David Macdonald, who will continue to work with GeneLink (Longwood, Florida) in a consulting capacity. Most recently, Mr Beeman was CEO and founder of Bay Hill Ventures, a private capital firm. He has also served as strategic planning director for GeneLink’s board, and director of marketing communications for GeneWize Life Sciences, a subsidiary of GeneLink. Meanwhile, Sharon Tahaney has been named president of GeneWize. She was previously senior vice-president of sales and marketing at the company.